Literature DB >> 24122180

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Frank van den Hoogen1, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira, Gabriela Riemekasten, Philip J Clements, Christopher P Denton, Oliver Distler, Yannick Allanore, Daniel E Furst, Armando Gabrielli, Maureen D Mayes, Jacob M van Laar, James R Seibold, Laszlo Czirjak, Virginia D Steen, Murat Inanc, Otylia Kowal-Bielecka, Ulf Müller-Ladner, Gabriele Valentini, Douglas J Veale, Madelon C Vonk, Ulrich A Walker, Lorinda Chung, David H Collier, Mary Ellen Csuka, Barri J Fessler, Serena Guiducci, Ariane Herrick, Vivien M Hsu, Sergio Jimenez, Bashar Kahaleh, Peter A Merkel, Stanislav Sierakowski, Richard M Silver, Robert W Simms, John Varga, Janet E Pope.   

Abstract

OBJECTIVE: The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present work, by a joint committee of the ACR and the European League Against Rheumatism (EULAR), was undertaken for the purpose of developing new classification criteria for SSc.
METHODS: Using consensus methods, 23 candidate items were arranged in a multicriteria additive point system with a threshold to classify cases as SSc. The classification system was reduced by clustering items and simplifying weights. The system was tested by 1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders, and 2) validating against the combined view of a group of experts on a set of cases with or without SSc.
RESULTS: It was determined that skin thickening of the fingers extending proximal to the metacarpophalangeal joints is sufficient for the patient to be classified as having SSc; if that is not present, 7 additive items apply, with varying weights for each: skin thickening of the fingers, fingertip lesions, telangiectasia, abnormal nailfold capillaries, interstitial lung disease or pulmonary arterial hypertension, Raynaud's phenomenon, and SSc-related autoantibodies. Sensitivity and specificity in the validation sample were, respectively, 0.91 and 0.92 for the new classification criteria and 0.75 and 0.72 for the 1980 ACR classification criteria. All selected cases were classified in accordance with consensus-based expert opinion. All cases classified as SSc according to the 1980 ACR criteria were classified as SSc with the new criteria, and several additional cases were now considered to be SSc.
CONCLUSION: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria for SSc and should allow for more patients to be classified correctly as having the disease.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2013        PMID: 24122180      PMCID: PMC3930146          DOI: 10.1002/art.38098

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  27 in total

Review 1.  Criteria for the classification of early systemic sclerosis.

Authors:  E C LeRoy; T A Medsger
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

2.  Autoantibodies in systemic sclerosis.

Authors:  Virginia D Steen
Journal:  Semin Arthritis Rheum       Date:  2005-08       Impact factor: 5.532

3.  Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Authors:  Jaap Fransen; Sindhu R Johnson; Frank van den Hoogen; Murray Baron; Yannick Allanore; Patricia E Carreira; László Czirják; Christopher P Denton; Oliver Distler; Daniel E Furst; Armando Gabrielli; Ariane Herrick; Murat Inanc; Bashar Kahaleh; Otylia Kowal-Bielecka; Thomas A Medsger; Ulf Mueller-Ladner; Gabriela Riemekasten; Stanislaw Sierakowski; Gabriele Valentini; Doug Veale; Madelon C Vonk; Ulrich Walker; Lorinda Chung; Philip J Clements; David H Collier; Mary E Csuka; Sergio Jimenez; Peter A Merkel; James R Seibold; Richard Silver; Virginia Steen; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

4.  Validation of potential classification criteria for systemic sclerosis.

Authors:  Sindhu R Johnson; Jaap Fransen; Dinesh Khanna; Murray Baron; Frank van den Hoogen; Thomas A Medsger; Christine A Peschken; Patricia E Carreira; Gabriela Riemekasten; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

5.  A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.

Authors:  F E Harper; H R Maricq; R E Turner; R W Lidman; E C Leroy
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965

6.  Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

Authors:  L S Lonzetti; F Joyal; J P Raynauld; A Roussin; J R Goulet; E Rich; D Choquette; Y Raymond; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-03

7.  Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.

Authors:  J Avouac; J Fransen; U A Walker; V Riccieri; V Smith; C Muller; I Miniati; I H Tarner; S Bellando Randone; M Cutolo; Y Allanore; O Distler; G Valentini; L Czirjak; U Müller-Ladner; D E Furst; A Tyndall; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2010-11-15       Impact factor: 19.103

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Preliminary criteria for the classification of systemic sclerosis (scleroderma).

Authors: 
Journal:  Bull Rheum Dis       Date:  1981

10.  Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

Authors:  Sindhu R Johnson; Raymond P Naden; Jaap Fransen; Frank van den Hoogen; Janet E Pope; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Christopher P Denton; Oliver Distler; Armando Gabrielli; Jacob M van Laar; Maureen Mayes; Virginia Steen; James R Seibold; Phillip Clements; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Lorinda Chung; Barri J Fessler; Peter A Merkel; Richard Silver; John Varga; Yannick Allanore; Ulf Mueller-Ladner; Madelon C Vonk; Ulrich A Walker; Susanna Cappelli; Dinesh Khanna
Journal:  J Clin Epidemiol       Date:  2014-04-08       Impact factor: 6.437

View more
  733 in total

1.  Technical feasibility of real-time elastography to assess the peri-oral region in patients affected by systemic sclerosis.

Authors:  Paola Maria Cannaò; Valeriano Vinci; Fabio Caviggioli; Marco Klinger; Davide Orlandi; Francesco Sardanelli; Giovanni Serafini; Luca Maria Sconfienza
Journal:  J Ultrasound       Date:  2014-07-29

2.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

3.  Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis.

Authors:  Lisa M Rice; Giuseppina Stifano; Jessica Ziemek; Robert Lafyatis
Journal:  Rheumatology (Oxford)       Date:  2015-09-05       Impact factor: 7.580

4.  High-resolution ultrasound of peripheral nerves in systemic sclerosis: a pilot study of computer-aided quantitative assessment of nerve density.

Authors:  Bianca Bignotti; Massimo Ghio; Nicoletta Panico; Giulio Tagliafico; Carlo Martinoli; Alberto Tagliafico
Journal:  Skeletal Radiol       Date:  2015-08-12       Impact factor: 2.199

5.  Mosaic capillaroscopic findings in systemic sclerosis.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Wien Med Wochenschr       Date:  2018-02-01

6.  Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.

Authors:  Rebecca De Lorenzo; Iago Pinal-Fernandez; Wilson Huang; Jemima Albayda; Eleni Tiniakou; Cheilonda Johnson; Jose C Milisenda; Maria Casal-Dominguez; Andrea M Corse; Sonye K Danoff; Lisa Christopher-Stine; Julie J Paik; Andrew L Mammen
Journal:  Neurology       Date:  2018-05-04       Impact factor: 9.910

7.  Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.

Authors:  Kimberly Showalter; Aileen Hoffmann; Gerald Rouleau; David Aaby; Jungwha Lee; Carrie Richardson; Jane Dematte; Rishi Agrawal; Rowland W Chang; Monique Hinchcliff
Journal:  J Rheumatol       Date:  2018-10-01       Impact factor: 4.666

8.  Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.

Authors:  Nezam Altorok; Pei-Suen Tsou; Patrick Coit; Dinesh Khanna; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2014-05-08       Impact factor: 19.103

9.  Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Authors:  Linda Kwakkenbos; Brett D Thombs; Dinesh Khanna; Marie-Eve Carrier; Murray Baron; Daniel E Furst; Karen Gottesman; Frank van den Hoogen; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Warren R Nielson; Serge Poiraudeau; Robert Riggs; Maureen Sauvé; Fredrick Wigley; Marie Hudson; Susan J Bartlett
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

10.  Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features.

Authors:  Claudio Corallo; Antonella Fioravanti; Sara Tenti; Gianluca Pecetti; Ranuccio Nuti; Nicola Giordano
Journal:  Rheumatol Int       Date:  2019-08-01       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.